Goodrx Net Invested Capital from 2010 to 2024

GDRX Stock  USD 4.90  0.61  14.22%   
Goodrx Holdings Net Invested Capital yearly trend continues to be fairly stable with very little volatility. Net Invested Capital will likely drop to about 899.8 M in 2024. Net Invested Capital is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. View All Fundamentals
 
Net Invested Capital  
First Reported
2010-12-31
Previous Quarter
1.4 B
Current Value
899.8 M
Quarterly Volatility
874.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Goodrx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Goodrx Holdings' main balance sheet or income statement drivers, such as Interest Income of 30.6 M, Depreciation And Amortization of 113.1 M or Interest Expense of 39.3 M, as well as many indicators such as Price To Sales Ratio of 3.48, Dividend Yield of 0.0599 or PTB Ratio of 3.43. Goodrx financial statements analysis is a perfect complement when working with Goodrx Holdings Valuation or Volatility modules.
  
Check out the analysis of Goodrx Holdings Correlation against competitors.
For more information on how to buy Goodrx Stock please use our How to Invest in Goodrx Holdings guide.

Latest Goodrx Holdings' Net Invested Capital Growth Pattern

Below is the plot of the Net Invested Capital of Goodrx Holdings over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Goodrx Holdings' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Goodrx Holdings' overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital10 Years Trend
Slightly volatile
   Net Invested Capital   
       Timeline  

Goodrx Net Invested Capital Regression Statistics

Arithmetic Mean152,425,391
Geometric Mean631,031,570
Coefficient Of Variation573.43
Mean Deviation787,017,721
Median(440,191,000)
Standard Deviation874,058,951
Sample Variance763979T
Range1.9B
R-Value0.79
Mean Square Error306653T
R-Squared0.63
Significance0.0004
Slope154,794,997
Total Sum of Squares10695706.7T

Goodrx Net Invested Capital History

2024899.8 M
20231.4 B
20221.5 B
20211.5 B
20201.4 B
2019-416.7 M

About Goodrx Holdings Financial Statements

Goodrx Holdings investors use historical fundamental indicators, such as Goodrx Holdings' Net Invested Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Goodrx Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Invested Capital1.4 B899.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Goodrx Stock Analysis

When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.